EHMT2 and neoplasm: Furthermore, in all the cancer cell line models that we tested in the immunodeficient mice, Ehmt2 loss alone was either less effective or not sufficient to induce tumor suppression, indicating that anti-tumor immunity, particularly NK cell-mediated cytotoxicity triggered by Ehmt2 loss, was key to in vivo tumor suppression.